London, 16. January 2018 - RebelBio, a life sciences accelerator of SOSV, the accelerator VC, launches its latest cohort in London.We're in the middle of the genomic revolution and the RebelBio accelerator has just launched a new cohort in London to accelerate some of the most astonishing developments in the life sciences.Increasing overlap with other technologies like machine learning, automation, faster DNA sequencing and synthesis are a few factors lowering the financial hurdles to entrepreneurship in the sector. In combination with capital, this enables entrepreneurs to de-risk their ventures earlier, pursue world-changing technologies and bring exciting consumer products to market.Synthetic biology company Bolt Threads is raising $106 million. Meanwhile, early-stage companies, too, are advancing in the funding cycle: IndieBio startup Memphis Meats has secured $17 million from investors that include Bill Gates. Our graduate cell-free tech has captured public imagination with their bio-pixel computer and several of our portfolio companies, like Microsynbiotix, have recently raised investment, too.Hence, to tap into this potential and support more entrepreneurs, RebelBio has expanded this year, running one program in Cork, Ireland and another one in London, UK.The team has selected a new batch of ten top early-stage companies to join the accelerator for 12 weeks. Each startup has won an investment of up to $250’000. The program takes place at the world-renowned Imperial White City Incubator. It consists of mentoring and workshop sessions, talks, pitch training and 1:1 sessions on business and scientific development with access to labspace and an advanced hackspace. It will culminate in a DemoDay in London at the end of March, where the entrepreneurs pitch to investors.The interdisciplinary companies are developing ground-breaking innovations in areas ranging from 3D cell cultures and stem cell manufacturing, AI-powered neural tech, de-centralized diagnostics and genomics to eco-fashion made from novel biomaterials and in human augmentation.
The 10 startups are:
AlgiKnit - Transforming the apparel ecosystem with rapidly re-newable bio-based textiles.
VivoKey Technologies - Your unforgettable digital identity solution
Encelo Laboratories - Universal access to stem cells
Chronomics - Epigenetic testing A.I platform to drive the future of personalised wellness
Visusnano - A novel medical device that will revolutionise cata-ract surgery
June (previously Corticare) - Personalised molecular health tracking anywhere and anytime
Magellan Life Sciences - Exploring new frontiers in sweet taste - the next generation non-caloric protein sweetener
Biomimetic Solutions - Developing innovative nanomaterials for re-generative medicine and 3D cell culture applications
Daekitech - Non invasive devices to diagnose and monitor chron-ic diseases, such as diabetes, with a disposable test strip that only uses saliva
Neurocreate - Neurofeedback and artificial intelligence, to aug-ment human cognition and achieve 'Flow' neurological states for peak performance and stress alleviation.
London, 16. January 2018 - RebelBio, a life sciences accelerator of SOSV, the accelerator VC, launches its latest cohort in London.We're in the middle of the genomic revolution and the RebelBio accelerator has just launched a new cohort in London to accelerate some of the most astonishing developments in the life sciences.Increasing overlap with other technologies like machine learning, automation, faster DNA sequencing and synthesis are a few factors lowering the financial hurdles to entrepreneurship in the sector. In combination with capital, this enables entrepreneurs to de-risk their ventures earlier, pursue world-changing technologies and bring exciting consumer products to market.Synthetic biology company Bolt Threads is raising $106 million. Meanwhile, early-stage companies, too, are advancing in the funding cycle: IndieBio startup Memphis Meats has secured $17 million from investors that include Bill Gates. Our graduate cell-free tech has captured public imagination with their bio-pixel computer and several of our portfolio companies, like Microsynbiotix, have recently raised investment, too.Hence, to tap into this potential and support more entrepreneurs, RebelBio has expanded this year, running one program in Cork, Ireland and another one in London, UK.The team has selected a new batch of ten top early-stage companies to join the accelerator for 12 weeks. Each startup has won an investment of up to $250’000. The program takes place at the world-renowned Imperial White City Incubator. It consists of mentoring and workshop sessions, talks, pitch training and 1:1 sessions on business and scientific development with access to labspace and an advanced hackspace. It will culminate in a DemoDay in London at the end of March, where the entrepreneurs pitch to investors.The interdisciplinary companies are developing ground-breaking innovations in areas ranging from 3D cell cultures and stem cell manufacturing, AI-powered neural tech, de-centralized diagnostics and genomics to eco-fashion made from novel biomaterials and in human augmentation.
The 10 startups are:
AlgiKnit - Transforming the apparel ecosystem with rapidly re-newable bio-based textiles.
VivoKey Technologies - Your unforgettable digital identity solution
Encelo Laboratories - Universal access to stem cells
Chronomics - Epigenetic testing A.I platform to drive the future of personalised wellness
Visusnano - A novel medical device that will revolutionise cata-ract surgery
June (previously Corticare) - Personalised molecular health tracking anywhere and anytime
Magellan Life Sciences - Exploring new frontiers in sweet taste - the next generation non-caloric protein sweetener
Biomimetic Solutions - Developing innovative nanomaterials for re-generative medicine and 3D cell culture applications
Daekitech - Non invasive devices to diagnose and monitor chron-ic diseases, such as diabetes, with a disposable test strip that only uses saliva
Neurocreate - Neurofeedback and artificial intelligence, to aug-ment human cognition and achieve 'Flow' neurological states for peak performance and stress alleviation.